Recent therapeutic advances have significantly improved the short‐and long‐term survival
rates in patients with heart disease and cancer. Survival in cancer patients may, however, be …

The advancement in therapy has provided a dramatic improvement in the rate of recovery
among cancer patients. However, this improved survival is also associated with enhanced …

As the number of cancer survivors has increased significantly over the last decades due to
aging of population and development of effective cancer therapies, side effects from cancer …

Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Damage to the heart can result from both traditional chemotherapeutic agents, such as
doxorubicin, and newer 'targeted 'therapies, such as trastuzumab. This chemotherapeutic …

Abstract Purpose of Review The goal of this review is to summarize current understanding of
pharmacogenetics and pharmacogenomics in chemotherapy-induced cardiotoxicity. Recent …

Toxicity to the heart and vascular system is a major concern with nearly all anticancer
agents. Toxicity can range from drug-induced hypertension, atherosclerosis (peripheral …

The cardiotoxicity of certain chemotherapeutic agents is now well-established, and has led
to the development of the field of cardio-oncology, increased cardiac screening of cancer …

Although cardiovascular toxicity from traditional chemotherapies has been well recognized
for decades, the recent explosion of effective novel targeted cancer therapies with …

Cardio-oncology is an emerging field that seeks to enhance quality of life and longevity of
cancer survivors. It is pertinent for clinicians to understand the cellular mechanisms of …